OOIR: Observatory of International Research

Papers

(The TQCC of Hypertension in Pregnancy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Inflammasomes in placental explants of women with preeclampsia cultured with monosodium urate may be modulated by vitamin D	16
Statement of Retraction: Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial	15
Effects of hypertensive disorders of pregnancy on the complications in very low birth weight neonates	15
Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China	14
Risk of gestational hypertension and preeclampsia in pregnant women with new onset blood pressure of 120–129/≤89 mmHg: a meta-analysis of prospective studies	12
Statement of Retraction: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section	11
Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials	11
Blood pressure medication use and postpartum hospital readmission among preeclampsia patients	11
Pre-eclampsia screening with maternal risk factors and ophthalmic Doppler artery: a systematic review	10
Expression of Concern: First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk	9
Intraabdominal pressure as a marker for physiologic and pathologic processes in pregnancy	9
Targeting oxidative stress in preeclampsia	8
WGCNA combined with machine learning for analysis of diagnostic markers of preeclampsia associated with the hedgehog signaling pathway	8
Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy	8
The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis	7
First-trimester maternal renin-angiotensin-aldosterone system activation and the association with maternal telomere length after natural and IVF/ICSI conceived pregnancies: the Rotterdam periconceptio	7
Trimester and severity of SARS-CoV-2 infection during pregnancy and risk of hypertensive disorders in pregnancy	6
Causal associations of metabolic dysfunction-associated steatotic liver disease with gestational hypertension and preeclampsia: a two-sample Mendelian randomization study	5
Distinguishing preeclampsia using the falling scaled slope (FSS) --- a novel photoplethysmographic morphological parameter	5
Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood	5
Use of the USCOM® noninvasive cardiac output measurement system to predict the development of pre-eclampsia in hypertensive pregnancies	5
The obesity associated FTO gene polymorphism and the risk of preeclampsia in Iranian women: A case–control study	4
Maternal and neonatal outcome among women with early-onset preeclampsia and late-onset preeclampsia	4
Magnesium sulfate improves blood flow of uterine, umbilical, and fetal middle cerebral arteries in women with severe preeclampsia at 30-34 gestational weeks	4
Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis	4

Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?